Bæk Møller, N.; Budolfsen, C.; Grimm, D.; Krüger, M.; Infanger, M.; Wehland, M.; E. Magnusson, N.
Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment. Int. J. Mol. Sci. 2019, 20, 4712.
https://doi.org/10.3390/ijms20194712
AMA Style
Bæk Møller N, Budolfsen C, Grimm D, Krüger M, Infanger M, Wehland M, E. Magnusson N.
Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment. International Journal of Molecular Sciences. 2019; 20(19):4712.
https://doi.org/10.3390/ijms20194712
Chicago/Turabian Style
Bæk Møller, Nanna, Cecilie Budolfsen, Daniela Grimm, Marcus Krüger, Manfred Infanger, Markus Wehland, and Nils E. Magnusson.
2019. "Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment" International Journal of Molecular Sciences 20, no. 19: 4712.
https://doi.org/10.3390/ijms20194712
APA Style
Bæk Møller, N., Budolfsen, C., Grimm, D., Krüger, M., Infanger, M., Wehland, M., & E. Magnusson, N.
(2019). Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment. International Journal of Molecular Sciences, 20(19), 4712.
https://doi.org/10.3390/ijms20194712